Goldman Sachs Group »

Bridgebio Pharma shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $710k 395k 1.80

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
State Str Spdr S&p 500 Etf T CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Tesla CMN (TSLA)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN (HYG)
Taiwan Semiconductor Manufac CMN (TSM)

View all positions for Goldman Sachs Group

Top funds holding Bridgebio Pharma

Wolverine Asset Management
Linden Advisors
Steelhead Partners
Capstone Investment Advisors
Lazard Asset Management
Millennium Management
FMR
Graham Capital Management
683 Capital Management
Aristeia Capital
Tenor Capital Management
M&G
State Street Corporation
DeepCurrents Investment Group
BlackRock

View all funds holding Bridgebio Pharma